Gergely Tóth, Ph.D., M.B.A.
Founder, Chief Executive Officer
Dr Gergely Tóth founded Gardedam Therapeutics in Palo Alto, CA in 2009 and is CEO of Cantabio Pharmaceuticals. Dr. Tóth is also affiliated with the Wolfson Brain Imaging Centre at University of Cambridge (UK) and with the Research Center for Natural Sciences at the Hungarian Academy of Sciences (Hungary) as the Head of the Research Group for Neurodegenerative Disease Drug Discovery. He is a scientist and a serial entrepreneur with a long-term focus on developing therapeutics for neurodegenerative diseases. He holds a Ph.D. from the Department of Biomedical Sciences at Creighton University (U.S.) in 2001, and an Executive M.B.A. in 2012 from the Judge Business School at the University of Cambridge (UK). He was a post-doctoral fellow at the Department of Molecular Biology at the University of California at Berkeley (U.S.). Dr. Tóth previously held various research roles in small and global biopharmaceutical companies in the U.S., where he mostly pursued drug discovery research for Parkinson’s disease and Alzheimer’s disease.
Simon Peace, M.Sc., M.B.A., A.C.M.A.
Chief Financial Officer
Simon Peace is the Chief Financial Officer of Cantabio Pharmaceuticals. Mr. Peace is a qualified accountant with extensive experience in medical technology and life sciences. In addition to holding CFO appointments in various small companies, he has accumulated extensive global business experience at SmithKline Beecham, Cable & Wireless, GE Capital and GE Healthcare. Most recently, Mr. Peace spent seven years practicing M&A in med-tech and life sciences at GE Healthcare, which saw him buying and selling businesses and setting up joint ventures across Europe, U.S., Russia and the Middle East. Mr. Peace is qualified to the Chartered Institute of Management Accountants and holds a B.Sc. in Natural Sciences from the University of Durham, an M.Sc. in Manufacturing Management from the University of Bradford and an Executive M.B.A. from the University of Cambridge Judge Business School. He is also a member of the Finance and Tax Advisory Committee of the BioIndustry Association.
Thomas Sawyer, Ph.D., M.B.A.
Chief Operations Officer
Dr. Thomas Sawyer is the Chief Operations Officer of Cantabio Pharmaceuticals, combining a background in academic research with 13 years of experience in entrepreneurship, consulting and private equity investment in sectors including biotechnology, IT, logistics and natural resources across the globe. He has worked on M&A activities for private and public companies in the U.S., Europe and Africa and has experience in raising capital, IPOs, mergers and in CEO/CTO roles for start-up and private equity backed ventures. Dr. Sawyer holds a Ph.D. in Life Sciences from the University of Glasgow, an Executive M.B.A. from the University of Cambridge and is a visiting lecturer on Corporate Finance at the University of Exeter. Dr. Sawyer combines a strong technical background with business development, corporate finance and operations, and is an active mentor on the Accelerate Cambridge business accelerator program at the University of Cambridge.